Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bonneterre

Showing results (21-30 of 194) with videos related to

Pageof 20
Sort By:
Current Opinion in Oncology|May 1, 1996
Current status of larynx preservation trialsJ L Lefebvre, J Bonneterre
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2005
Reply to the article "A monoclonal antibody against HER-2 (trastuzumab) for metastatic breast cancer: a model based cost-effectiveness analysis", by J. Norum et al. (Ann Oncol 2005; 16: 909-914)M E Bonneterre, J Bonneterre
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Prophylactic cranial irradiation for lung cancer patientsJ F Minne, J Bonneterre
Breast Cancer Research and Treatment|January 1, 1992
Type 1 IGF receptor in human breast diseasesJ P Peyrat, J Bonneterre
European Journal of Cancer & Clinical Oncology|July 1, 1989
Prolactin receptors (PRL-R) and breast cancerJ Bonneterre, J P Peyrat
Bulletin Du Cancer|November 26, 1999
[Aromatase inhibitors]M L Feutrie, J Bonneterre
Pathologie-Biologie|November 1, 1989
[Weight gain under adjuvant chemotherapy]J Bonneterre, P Vennin, A Demaille
La Revue De Medecine Interne|January 1, 1994
[Antiemetic treatment and chemotherapy: general review]S Lecomte, A Adenis, J Bonneterre
Gastroenterology|December 1, 1992
Statistical analysis of crossover studiesA Adenis, B Hecquet, J Bonneterre
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2005
Chemotherapy-induced amenorrhea: influence on disease-free survival and overall survival in receptor-positive premenopausal early breast cancer patientsM Vanhuyse, C Fournier, J Bonneterre
Pageof 20

Showing results (21-30 of 194) with videos related to

Sort By:
Pageof 20
Current Opinion in Oncology|May 1, 1996
Current status of larynx preservation trialsJ L Lefebvre, J Bonneterre
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2005
Reply to the article "A monoclonal antibody against HER-2 (trastuzumab) for metastatic breast cancer: a model based cost-effectiveness analysis", by J. Norum et al. (Ann Oncol 2005; 16: 909-914)M E Bonneterre, J Bonneterre
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Prophylactic cranial irradiation for lung cancer patientsJ F Minne, J Bonneterre
Breast Cancer Research and Treatment|January 1, 1992
Type 1 IGF receptor in human breast diseasesJ P Peyrat, J Bonneterre
European Journal of Cancer & Clinical Oncology|July 1, 1989
Prolactin receptors (PRL-R) and breast cancerJ Bonneterre, J P Peyrat
Bulletin Du Cancer|November 26, 1999
[Aromatase inhibitors]M L Feutrie, J Bonneterre
Pathologie-Biologie|November 1, 1989
[Weight gain under adjuvant chemotherapy]J Bonneterre, P Vennin, A Demaille
La Revue De Medecine Interne|January 1, 1994
[Antiemetic treatment and chemotherapy: general review]S Lecomte, A Adenis, J Bonneterre
Gastroenterology|December 1, 1992
Statistical analysis of crossover studiesA Adenis, B Hecquet, J Bonneterre
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2005
Chemotherapy-induced amenorrhea: influence on disease-free survival and overall survival in receptor-positive premenopausal early breast cancer patientsM Vanhuyse, C Fournier, J Bonneterre
Pageof 20